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This newsletter was jointly developed and 
subject to editorial review by Jefferson 
School of Population Health and Lilly 
USA, LLC, and is supported through 
funding by Lilly USA, LLC. The content 
and viewpoints expressed are those of the 
individual authors, and are not necessarily 
those of Lilly USA, LLC or the Jefferson 
School of Population Health.
Because this is the final issue in our 
series featuring multistakeholder 
viewpoints on health care reform, it is 
only fitting that I devote my editorial 
to the singular event that colored every 
article - the Supreme Court decision 
regarding the constitutionality of the 
Patient Protection and Affordable  
Care Act (ACA).
Of all the commentary I read on 
the topic, Time Magazine’s “Special 
Report: The Health Care Decision” 
struck me as the most balanced and 
comprehensive. Lead author David 
Von Drehle’s analysis of the legal 
gymnastics that turned a potential 
zero-sum game into a win-win 
situation was fascinating, as was his 
profile of the man behind the decision, 
Chief Justice John Roberts.1 
Controversies will continue to foment, 
but 2 things are certain: (1) Health care 
reform as laid out in the contentious 
ACA is constitutional, and (2) Congress 
“may not hold states hostage to its every 
whim,” (ie, the federal government 
cannot force states to adopt the Medicaid 
expansion provision, a key element in the 
pursuit of universal coverage).
So, what does this mean for the average 
American beginning in 2014?
For the first time in our history, almost 
everyone will be required to have 
health insurance. The most notable 
exceptions are those for whom available 
coverage options would exceed 8% of 
their income. Insurers will be required 
to price and sell policies to everyone, 
regardless of their health status. For 
young adults older than age 26, it 
means paying a financial penalty for 
being uninsured. For low- to middle-
income earners, it means the possibility 
of qualifying for state Medicaid 
programs or federal subsidies to help 
pay for health insurance. For those with 
“preexisting conditions,” it means that 
insurance companies will be prohibited 
from denying insurance and charging 
higher prices. Because insurers will be 
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barred from setting premiums based 
on risk, it is likely that we all will pay 
a little more for our health coverage.
The law includes some taxes on 
industries that are expected to gain 
from it (eg, medical device makers, 
pharmaceutical companies). It raises 
the Medicare tax rate for families 
earning more than $250,000 a year 
and cuts some Medicare spending 
(eg, reduced reimbursement for the 
costlier than estimated Medicare 
Advantage program). Although such 
taxes and cuts are never popular, they 
are good policy. 
Whether in the government or private 
sector, those of us who are engaged in 
health care administration and delivery 
will continue to work to implement 
the ACA’s ambitious, broad-reaching 
reforms. Some entities will almost 
certainly continue to undermine reform 
efforts; for example, will the 26 states 
that challenged the Medicaid expansion 
provision of the ACA now opt out 
and, if so, how many millions will 
remain without coverage? The decision 
likely will have its most intense effect 
in the political arena, the upcoming 
presidential election in particular. 
The health economic piece may 
prove to be the biggest challenge. As 
economics professor Christina D. 
Romers observed in her New York 
Times article, “Only the First Step in 
Containing Health Costs,”2 serious 
discussion of additional cost-saving 
measures may be a long way off. 
The reason: Instead of focusing on 
ways to make the entire health care 
system more efficient, Republicans 
seem more interested in limiting the 
government’s share of health care 
expenditures and Democrats seem 
more interested in preserving existing 
government programs. 
Given the foregoing “backdrop,” I 
think that the 3 articles in this issue 
wrap up the series perfectly. The 
first, “The Supreme Court and Health 
Reform: A Practical Perspective,” is 
a very timely and comprehensive 
discussion of the ACA - from its 
passage, to the Supreme Court 
decision, to its implications for 
all stakeholders. “A Perspective: 
Through the Eye of the Beholder – 
Gauging Health Care Value” makes 
a compelling case for understanding 
the core components of “value,” 
with particular emphasis on the 
often overlooked patient/consumer 
perspective. At first glance, the final 
article, “A Black Swan Comes to 
Philadelphia,” may seem like mere 
whimsical exaggeration. But, without 
the kind of health care system reforms 
initiated by the ACA, it may become 
a painful reality. 
As always, I welcome comments, 
suggestions, and questions from  
our readers. I can be reached at:  
david.nash@jefferson.edu
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For the past few months, focus has 
been on the Supreme Court and what 
it might say regarding the Affordable 
Care Act (ACA). Now that it has 
made its decision, what’s next? The 
first thing to consider is that health 
care reform is more of a continuing 
effort than simply an event. Given 
current politics, new technologies, and 
a volatile economy, ongoing reform 
may be the “new normal.” 
Going forward, the legal community 
will be called upon to interpret the 
continuous change as companies make 
business decisions and to counsel 
clients on how to be compliant in 
this evolving landscape. The latter 
point is complicated by a legal system 
wherein the laws governing how 
companies are to behave often lag 
behind the realities of the health care 
environment (an environment that 
increasingly is being shaped by the 
government through laws such as 
ACA). In many instances, laws were 
written to address circumstances that 
are no longer relevant or nonexistent. 
It follows that another role of the 
health care lawyer is to assess where 
and how laws can be reformed.
Before discussing some laws that 
need updating to further reform, it is 
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important to note that such hopeful 
changes will take time. So what 
should be done in the short run? 
In order to deal with continuous 
change, the key is to stay grounded 
and avoid making legal concepts 
any more complicated than they are. 
Many basic concepts that predate 
the ACA will continue throughout 
all of the reforms. 
As a rule, the following points are 
at issue: (1) Is the right patient 
getting the right treatment? (2) 
Are providers getting the right 
information in order to make the 
best decisions for the patient? (3) 
Are payers paying what they should? 
(4) Are the financial relationships 
between the players in the health 
care sector appropriate and not 
creating incentives for bad behavior? 
In the absence of clear guidance, if a 
contemplated action causes anxiety 
with respect to the 4 points above, it 
certainly requires further scrutiny by 
a legal team and, beyond that, simply 
may not be the right thing to do.
Our continuous health care reform 
has not changed any of the above but 
it has made the situation more acute. 
In particular, as the government 
plays a larger role, federal and state 
fiscal challenges will continue. 
Approximately 10,000 people turn 
age 65 every day. Costs will continue 
to rise and those who pay those costs 
will wonder how the money is being 
spent. This leads to an increased 
emphasis on compliance. 
What laws need reform? We 
need laws that allow for more 
collaboration between the 
participants in the health care 
industry rather than less. An example 
of a positive action along those 
lines is the effort by the Centers for 
Medicare and Medicaid Services 
and the Office of the Inspector 
General to develop fraud and 
abuse waivers for certain beneficial 
Accountable Care Organization 
arrangements. On a less positive 
note, many potential opportunities 
between the pharmaceutical industry 
and providers may be missed when 
an industry member cannot find 
a way to enter into a program 
with a provider and still be able to 
account for it in its Government 
Price Reporting in the Medicaid 
and Medicare programs, if required. 
Steps must be taken to assure that 
new scientific information is relayed 
quickly and thoroughly to provide 
decision makers with the most 
complete information available. 
A vibrant marketplace where 
participants have financial incentives 
to do better is a great way to improve 
the abilities of all involved. However, 
some are concerned that such 
incentives may lead to bad behavior. 
Often these fears lead policy makers 
and enforcement agencies to create 
and enforce laws that curtail the 
“right” behaviors to promote good 
health care. For this reason, some laws 
actually may be prohibiting reform 
or moving further away from it. To 
overcome such skepticism, different 
stakeholders in the health care sector 
must agree on a best practice (that 
existing laws may be preventing) 
and work together to create legal 
reform. This reform could allow 
innovative practices to spring forward, 
benefitting the health care system and 
the patients its serves.
Steven C. Benz, Esq., is Assistant 
General Counsel, Managed Healthcare 
Services and Governmental Affairs for 
Eli Lilly and Company.
 
On June 28, 2012, the US Supreme 
Court issued its holding in the initial 
challenges to the constitutionality of  
the Patient Protection and Affordable 
Care Act (“ACA”) in the case of National 
Federation of Independent Business (NFIB) 
et al v. Sebelius (Slip Opinion of Case 11-
393 on certiorari to the Supreme Court.) 
This decision will dramatically impact 
both the future of the nation’s health and 
the nature of relationships for US health 
care programs. 
The 900-page ACA legislation (or 
“Obamacare” as it is known, derisively or 
colloquially depending upon the user’s 
political perspective) promised to extend 
universal health insurance coverage to all 
The Supreme Court and Health Reform: A Practical Perspective
By Howard A. Burde, Esq. 
(continued on page 4)
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Americans and was touted as the 
long-awaited health reform to cure 
manifest problems with cost, access, 
and perverse incentives in the health 
care system. In reality, it was and 
is far less. In fairness, it was and is 
a consequential attempt to extend 
health insurance coverage to a large 
number of adults formerly not covered 
by insurance, either by choice or 
circumstance. However, the ACA 
provides little in the way of systemic, 
structural, or payment reform. Thus, 
the ACA is about coverage, not 
reform. The purpose of this article is to 
describe the components of the ACA 
at issue in the NFIB v. Sibelious, and to 
discuss the implications of the decision 
on the ACA itself, state and federal 
governments, consumers, employers, 
providers, and payers.
Background 
The ACA attempts to increase access 
to health insurance coverage while 
expanding federal and private health 
insurance market requirements, 
and requires the creation of health 
insurance exchanges (HIEs) to provide 
individuals and small employers with 
access to insurance. Among other 
provisions, ACA increases access to 
health insurance coverage by: (1) 
expanding Medicaid eligibility by 
mandating that individuals obtain 
health coverage and that employers 
provide it, (2) extending funding 
for the Children’s Health Insurance 
Program (CHIP), and (3) subsidizing 
private insurance premiums and cost 
sharing for certain lower-income 
individuals enrolled in exchange plans. 
These costs are projected to be offset 
by increased taxes and other revenues 
and reduced Medicare and Medicaid 
spending. The law also includes 
measures to collect information and to 
explore new ways to enhance delivery 
and quality of care.
The major expansion and reform 
provisions in ACA take effect in 
2014. State Medicaid programs will 
be required to expand coverage to all 
eligible nonpregnant, non-elderly legal 
residents with incomes up to 133% 
of the federal poverty level (FPL). 
The actual percentage works out to be 
138% because the first 5% of income 
is disregarded for Medicaid eligibility 
determinations. The federal government 
will initially cover all the costs for 
this group, with the federal matching 
percentage phased down to 90% of the 
costs by 2020. The law requires states 
to maintain the current CHIP structure 
through fiscal year (FY) 2019, and 
provides federal CHIP appropriations 
through FY2015, thus extending CHIP 
funding by 2 years. 
States are incentivized to establish HIEs 
that provide access to private health 
insurance plans with standardized benefit 
and cost-sharing packages for eligible 
individuals and small employers. In 
2017, states may allow larger employers 
to purchase health insurance through 
the exchanges, but are not required to 
do so. The Secretary of Health and 
Human Services (HHS) is empowered 
to establish HIEs in states that do not 
create their own approved exchange.
Premium credits and cost-sharing 
subsidies will be available to individuals 
who enroll in HIE plans, provided their 
income is generally above 100% and 
no more than 400% of the FPL and 
they meet other requirements. Also 
beginning in 2014, most individuals will 
be required to have health insurance 
or pay a tax penalty (the “individual 
mandate”). Employers with more than 
50 employees that do not offer health 
insurance may be subject to penalties. 
Such employers that do not meet the 
law’s requirement by offering qualified 
health insurance products, or whose 
full-time workers enroll in HIE plans 
and receive premium subsidies, will pay 
a penalty. 
ACA’s federal health insurance 
requirements are further expanded 
in 2014, with no annual dollar limits 
permitted on essential health benefits 
and no exclusions permitted for 
preexisting conditions or the patient’s 
age. Plans offered within HIEs and 
certain other plans also must meet 
criteria of essential benefit standards (eg, 
covering emergency services, hospital 
care, physician services, preventive 
services, prescription drugs, and mental 
health and substance use disorder 
services). Premiums may vary by limited 
amounts based on age (3:1), family size, 
geographic area, and tobacco use (1.5:1). 
Plans must sell and renew policies to all 
individuals and may not discriminate 
based on health status. 
Employers face additional – and costly –
new requirements such as new increases 
in benefits and premium costs, and new 
taxes on premiums passed through to 
employers. Moreover, the ACA contains 
a number of new “soft costs” that are 
rarely discussed in the public arena but 
which add significantly to the employer 
burden regardless of the insurance 
changes (eg, withholding changes, 
mandates for reporting the value of 
health coverage, uniform summary of 
benefits and coverage, summaries of 
material modifications, auto-enrollment, 
new taxes on high earners, new taxes on 
high-benefit plans).
(Note: The material in the foregoing 
section is derived from the language 
of the ACA and from Congressional 
Research Services reports, most 
notably PPACA: A Brief Overview of 
the Law, Implementation, and Legal 
Challenges [Chaikind H, et al. CRS 
March 2, 2011].)
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Summary of the Supreme Court’s Decision in 
NFIB v. Sebelius 
The Supreme Court considered 
4 questions:
1.  Does the Anti-Injunction Act 
preclude consideration of the 
mandate as a tax prior to 2014?
2.  Is it constitutional for Congress to 
mandate that all individuals purchase 
or maintain health coverage?
3.  If the mandate were unconstitutional, 
would it be severable from the 
remainder of the ACA, or would the 
entire Act be unconstitutional?
4.  Is the Medicaid expansion under the 
ACA constitutional?
Initially, the Supreme Court held that 
the Anti-Injunction Act does not 
preclude consideration of the mandate 
as a tax because Congress called the 
mandate a penalty.
Having satisfied the threshold question, 
the Supreme Court decided that the 
individual mandate was unconstitutional 
under Congress’ Commerce Clause 
powers, but that it could be read as a tax 
and therefore was constitutional under 
Congress’s power to tax and spend. This 
is the most controversial component of 
the decision. Indeed, only Chief Justice 
Roberts held this opinion. Four Justices 
agreed that the individual mandate was 
unconstitutional under the Commerce 
Clause (Kennedy, Scalia, Alito, and 
Thomas), making a majority for that 
part of the Chief Justice’s decision. Even 
though they believe it is constitutional 
under the Commerce Clause, the 4 
other Justices (Ginsberg, Breyer, Kagan, 
and Sotomayor) agreed to uphold the 
individual mandate as a tax, making a 
majority opinion to uphold the individual 
mandate. Because the individual mandate 
was ruled constitutional, the severability 
question was moot.
Finally, the court held that Congress 
could not condition a state’s receipt of 
funds for an existing program on the 
expansion of that program or a new 
program. Therefore, the Medicaid 
expansion to new populations was ruled 
to be unconstitutional if mandatory for 
states. States may opt to expand, but 
cannot be forced to do so.
What the Supreme Court’s Decision Means
The Individual Mandate 
To understand the Court’s decision, it 
is helpful to understand the underlying 
provision of the Constitution. The 
opening paragraph of Article I, Section 
8, which provides the powers of 
Congress, states that, “Congress shall 
have the power to lay and collect taxes, 
duties, imposts and excises, to pay the 
debts and provide for the common 
defense and general welfare of the 
United States.” Several additional clauses 
“enumerate” the powers of Congress to 
which the opening paragraph applies, 
and among these enumerated powers 
is the power under Article I, Section 8, 
Clause 3, to “regulate commerce with 
foreign nations and among the several 
states and with Indian tribes.” This is 
known as the “Commerce Clause.”
In defending the mandate, Congress 
and the Obama administration asserted 
that the Commerce Clause was plenary 
and without limitation because every 
act or non-act would impact commerce. 
Indeed, the history of the Supreme Court 
Commerce Clause jurisprudence since the 
New Deal is one of steady expansion of 
Congress’ authority to regulate under the 
Commerce Clause. Chief Justice Roberts 
noted that “the power of Congress over 
interstate commerce is not confined to 
the regulation of commerce among the 
states but extends to activities that ‘have a 
substantial effect on interstate commerce.’” 
The Chief Justice further noted that 
Congress’s power is “not limited to the 
regulation of an activity that by itself 
substantially affects interstate commerce, 
but also extends to activities that do so 
only when aggregated with the activities 
of others.” “But,” the Chief Justice 
noted, “Congress has never attempted to 
rely on that power to compel individuals 
not engaged in commerce to purchase an 
unwanted product.”
The court held that the power to regulate 
commerce “presupposes the existence 
of commercial activity to be regulated.” 
There must be actual activity and 
Congress does not have the authority 
to compel activity to then regulate. 
Moreover, the Chief Justice held that 
Congress cannot regulate individuals 
because they are not engaged in an 
activity, or as he stated, “doing nothing.” 
“Every day individuals do not do an 
infinite number of things” and “Congress 
is not empowered to regulate that 
absence of activity or to mandate activity 
under the Commerce Clause.”
By contrast, Congress’ power to lay and 
collect taxes is considered plenary. It is 
accepted jurisprudence that Congress’ 
power to tax is virtually unlimited 
constitutionally, but is generally limited 
politically. The Chief Justice notes that 
the ACA does not describe the penalty 
for not having health coverage as a tax. 
Indeed, central to the political debate 
leading to passage of the law was the 
insistence of Congress and the President 
that the law did not raise taxes, but that 
the mandate was a “shared responsibility 
payment.” The fear, of course, was that 
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if the mandate were considered a tax, it 
would have been more difficult to get the 
votes to pass the bill.
On July 24, 2012, the Congressional 
Budget Office announced that the 
decision itself changed the tax calculus to 
add $4 billion in new taxes on businesses 
and $1.5 billion in new taxes for 
individuals. In fact, ACA raises over $1 
trillion in taxes, inclusive of the mandate 
being a tax, and diverts over $500 billion 
from the Medicare program. 
Ultimately, this part of the decision 
means that the mandate tax is now 
subject to a simple calculus for 
individuals. The question becomes one 
of whether it is more cost-effective 
to obtain coverage in advance or to 
risk paying the penalty and obtain the 
coverage only when needed. Because 
of the guaranteed issue provisions of 
the ACA, an individual can obtain 
coverage at any time. Without an 
enforceable law, there is only a tax 
to compel an individual to obtain 
coverage prior to an illness.
In a broader sense, the holding means 
that future expansions of federal authority 
likely would be justified as constitutional 
under the taxing and spending power, a 
higher bar to reach politically.
Medicaid Expansion 
The Supreme Court also held that 
Congress could not mandate state 
expansion of the Medicaid program 
to new populations. Recall that half 
of the anticipated additional coverage, 
approximately 16 million lives, would 
have been through the Medicaid 
program. Given the problems with 
the Medicaid program as currently 
structured, 27 states representing 
approximately 40% of the anticipated 
new lives challenged the expansion. 
Although politics may have played some 
part in the challenge, the Medicaid 
programs in most states are problematic 
from both administrative and budget 
perspectives. Even with a federal 
promise to pay for the increase of nearly 
all of the Medicaid expansion in the 
short term, adding 16 million more 
lives to the program was and is not 
considered practical for the governors of 
those states.
The Supreme Court’s decision validated 
the challenge, reviving a state’s ability to 
determine whether or not to participate 
in a federally funded program. To date, 
7 states with 20% of the anticipated new 
lives to be covered have already opted 
out and another 9 are considered likely 
to do so. Two reasons predominate. 
First, the federal promise of full funding 
is ephemeral. Once an entitlement is in 
place it cannot be withdrawn without 
a huge political and legal battle. If the 
federal money were to be reduced, 
the states would be stuck with the bill 
and forced to either generate revenue 
through taxes or reduce other programs 
(eg, infrastructure, transportation, 
education) to pay for the federal 
mandate. State budgets are littered with 
unfunded or partially funded federally 
mandated programs. Adding another at 
a time when state budgets are already 
stressed makes no fiscal sense. Second, 
the limited budget reduction proposals 
from the Obama administration 
already call for a reduction of federal 
financial participation for the Medicaid 
expansion and for CHIP participation. 
Even though the Obama administration 
has not passed a budget for 3 fiscal 
years, it has already signaled to the 
states that the federal matching funds 
are at risk. Under such circumstances, 
it can be argued that implementation 
of the Medicaid expansion is political, 
while declining to do so is pragmatic.
The Supreme Court’s decision on 
the Medicaid expansion has further 
implications for the relationship between 
the federal and state governments. 
Programs such as nutrition, education, 
transportation, aging, and Medicaid 
are administered by states under 
formulas that include federal financial 
participation. The states must submit 
extensive “State Plans” for federal 
approval in order to draw down the 
federal funds. The states also file for 
waivers from federal requirements in 
order to run the programs in more 
effective ways. By limiting the federal 
leverage over states, the Supreme Court 
has created the opportunity for states to 
seek federal funds without significant 
bureaucratic conditions and with 
dramatically new structures. 
The states argue that, being closer to the 
delivery of services, they know how to 
best deploy the resources without a layer 
of bureaucratic oversight. Indeed, there 
is no evidence that state bureaucrats are 
any less educated, dedicated, or able than 
federal ones. State bureaucrats simply 
work for less money in less exciting 
places. Effectively, the Court’s decision 
creates the conditions for a new balance 
of federal and state authority with respect 
to federally funded programs. Note 
that several states are in the process of 
structuring alternatives to the Medicaid 
expansion for federal consideration. 
These alternatives may include revised 
benefit structures for both the new and 
existing components of the Medicaid 
population, such as the expansion of 
existing but less expensive programs 
like SCHIP, mini-med or catastrophic 
programs, or yet undetermined choices. 
This leads to issues of the flexibility of 
the ACA language to permit alternative 
structures and the willingness of the 
Department of HHS to grant waivers 
for restructuring. Ultimately, the 
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ability to offer alternatives is a positive 
opportunity to reach toward universal 
coverage without undermining state 
fiscal structures.
Impact on Consumers and Employers 
The net impact of the Supreme Court 
decision on consumers is to make the 
individual mandate less compelling. 
Because the tax is both low and not 
subject to enforcement, there is little 
to compel individuals to purchase 
insurance before they need it. The 
annual tax for not having minimum 
essential coverage will be the greater of 
a flat dollar amount per individual or a 
percentage of the individual’s taxable 
income. For any dependent younger 
than age 18, the penalty is one half 
of the individual amount. The flat 
dollar amount per individual is $95 in 
2014; $325 in 2015, and $695 in 2016. 
After 2016, the flat dollar amount is 
indexed to inflation. The flat dollar 
penalty is capped at 300% of the flat 
dollar amount. The percentage of 
taxable income is an amount equal to 
a percentage of a household’s income 
(as defined by the Act) that is in excess 
of the tax filing threshold (phased 
in at 1% in 2014; 2% in 2015; 2.5% 
in 2016). The tax will be reflected as 
a federal tax liability on income tax 
returns and is enforced by the Treasury. 
Individuals who fail to pay the 
penalty will not be subject to criminal 
penalties, liens, or levies.
The essential benefit packages mandated 
by the ACA are very rich and include 
the costs associated with taxes on 
medical devices, on premiums, and on 
executive policies. So, individuals have a 
choice: They can purchase a rich benefit 
package with associated taxes from day 
1, or risk paying a small tax and either 
purchase the insurance as they need it 
or purchase less expensive but adequate 
coverage outside the HIEs. 
If an average individual policy is $500 per 
month, skipping even 1 month makes 
economic sense. Because preexisting 
conditions cannot be used to deny 
coverage, an individual can wait until he 
or she is diagnosed with an illness. Other 
than to cover a potential accident that 
requires emergency room care, it does 
not make economic sense to purchase 
coverage. Even then, other insurance 
(eg, automobile, homeowners) might 
cover many of the potential accidents 
that would require emergency room 
care. Of course there are also strong 
reasons to obtain health insurance - in 
addition to satisfying the tax mandate, 
qualified coverage provides both peace 
of mind and rich benefits that help avoid 
preventable conditions and maintain 
health status. 
It is worth noting that under the 
Medicare Part D benefit, those who 
decline to obtain coverage until they 
need it pay a surcharge, making it less 
economically beneficial to wait. This 
disincentive to wait combined with the 
fact that the eligible population is elderly 
and more likely to require prescription 
drugs on a regular basis has resulted in 
close to universal adoption and far lower 
than anticipated costs.
For employers, the economics are similar. 
The tax incentive applies to firms with 
more than 50 employees. Companies 
that do not offer health insurance and 
have at least 1 employee receiving 
insurance subsidies must pay a tax of 
$2000 per employee not covered by 
insurance (excluding the first 30). For 
example, a firm adding a 51st employee 
would pay $42,000 in new annual taxes 
plus an additional $2000. Effectively, a 
company must view the new employee as 
worth more than $42,000 in additional 
net profit (over the amount needed to 
justify the new employee in the first 
place) or the cost of providing health 
coverage to all employees, a massive 
disincentive for small businesses. 
Employers are not required to pay an 
assessment for employees who work less 
than 30 hours per week or employees 
hired for less than 120 days, seasonal 
employees, or retail workers hired 
exclusively during the holiday season. 
Taken to extremes, the employer-related 
mandates may lead to a system wherein 
people are employed by smaller employers 
or are employed on a part-time rather 
than full-time basis. Current employees 
or distinct components of businesses 
would be spun off into smaller companies 
or treated as independent contractors. 
Large employers will need to make a 
slightly different calculation - determine 
the per-employee cost implications of 
providing health coverage and compare 
that cost to the cost of dropping the 
plan, paying the penalty, and reimbursing 
the employee for his or her employee 
mandate fee. Employers with more than 
200 employees must automatically enroll 
all full-time employees as soon as they 
are eligible. The Supreme Court did not 
change this fundamental calculation but, 
by upholding the law, it forced companies 
to focus on the decision of whether or 
not, or how, to provide health coverage for 
employees. Because the first year of the 
Employer Mandate is 2014, the decision 
must be made in time for a benefits 
selection process in the fall of 2013.
All larger employers must report, but not 
tax, the cost of providing coverage on the 
W-2 forms of employees. More highly 
compensated employees are subject to 
additional Medicare payroll taxes of 3.8%. 
The new portion of the payroll tax will 
be devoted to ACA implementation. 
Smaller employers are entitled to grants 
and other incentives to provide care and 
will be eligible to obtain coverage through 
the state HIEs. 
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Introduction 
Few concepts in health care have 
promoted more discussion, prompted 
more interventions, and sustained more 
controversy than the desire to objectify 
and measure value. Measures of diverse 
attributes of value have multiplied 
while conceptual and action-oriented 
frameworks to position measurement 
findings and to reconcile ambiguities 
compete for attention. Refinement in 
measure development and validation is 
occurring in concert with generalized 
agreement that the ability to robustly and 
accurately measure attributes of value is 
core to evolving and sustaining an effective 
and equitable health system. However, 
as the desire and ability to reflect aspects 
of value has advanced, the importance of 
linking the meaning of value to the needs 
and beliefs of various key stakeholders in 
the health care system also has escalated. 
In short, the more we learn about 
measuring value, the more there is yet 
to learn about ensuring that the results 
of measurement are broadly informative 
and engaging. The following identifies 
some considerations about, and current 
gaps in, what may be involved in more 
completely pursuing broadly engaging 
value measurement and realization. 
The Need to Create and Demonstrate Value…
Now, More Than Ever… 
The importance of demonstrating the 
value of health care services and delivery 
A Perspective: Through the Eye of the Beholder – Gauging Health Care Value
By Paul Wallace, MD
Payers and Providers 
Payer community support for the ACA 
was based on an understanding that 
the individual mandate would provide 
millions of new lives to cover; therefore, 
the mandatory essential benefit packages, 
medical loss ratio, premium taxes, 
guaranteed issue, and prohibition on 
preexisting conditions and on annual and 
lifetime benefits would be less pressing. 
Nothing in the law prohibits health 
plans from developing actuarially sound 
premiums to cover those costs, and 
nothing in the law actually limits costs. 
Frankly, health plans make money on 
each life and the higher the premium, 
the higher the profit. If a problem exists, 
it is with those individuals who obtain 
coverage only when they need it - and 
therein lies the rub of the Supreme Court 
opinion for payers. Because the decision 
makes it more likely that individuals will 
not obtain coverage until they need it, 
health plans will be unable to anticipate 
reserves for such individuals, adding 
uncertainty to the premium calculation. 
And fewer individuals obtaining coverage 
means less profit.
Because universal coverage was the 
incentive for hospitals to accept 
cuts in Medicare and Medicaid 
reimbursement, hospitals will suffer. 
The cuts include a 2% sequestration 
across the board; reductions in market 
basket updates for hospital care; 
decreases in imaging reimbursement; 
penalties for “potentially avoidable 
readmissions”; Disproportionate Share 
hospital reimbursement cuts; value-based 
purchasing for cardiac, surgical, and 
pneumonia services; hospital-acquired 
condition penalties; and the bundling of 
post-acute care services. 
To the extent that states decide not 
to expand Medicaid, and individual 
and employer mandates do not lead to 
anticipated increases in covered lives, 
the Supreme Court decision likely will 
have an adverse impact on hospitals. The 
reduction in anticipated covered lives 
and the willingness of Congress and the 
Department of HHS to reconsider the 
reductions will determine the extent of 
the adversity.
Conclusion  
Although the public and media focus on 
the Supreme Court’s NFIB v. Sebelius 
decision has been on determining 
winners and losers, a far more interesting 
dynamic is apparent. Inside Washington, 
DC, the bill’s proponents and opponents 
remain unchanged. Outside the 
“Beltway,” the states, businesses, and 
individuals dealing with the ACA are 
focused less on the politics and more on 
the financial, legal, and administrative 
implications. The ACA is an ambitious 
piece of legislation that covers a great 
range of health care issues. Its attempt 
to reach near universal coverage is a goal 
to which there is almost no opposition, 
yet the means to achieve it are incredibly 
burdensome. The wisdom of the 
Supreme Court’s decision is that it creates 
the atmosphere for states to develop more 
creative approaches and forces the issue 
with respect to individuals obtaining 
coverage. However unintended, the 
decision is spurring a reconsideration of 
the means to achieve universal coverage. 
Howard A. Burde, Esq., is Principal of 
Howard Burde Health Law, LLC. He can 
be reached at: howard@burdelaw.com. 
DISCLAIMER: This article does not 
constitute legal advice. For advice on the 
provisions of the ACA, please contact 
your own attorney.
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system change has intensified with the 
passage of the Patient Protection and 
Affordable Care Act (ACA) health reform 
legislation in 2010, in combination with 
the other extraordinary public investments 
in the last decade in health services (eg, 
the Medicare Prescription Drug Benefit 
part of the 2003 Medicare Modernization 
Act, elements of The American Recovery 
and Reinvestment Act of 2009 and its 
Health Information Technology for 
Economic and Clinical Health Act). 
A public focus of this amplified scrutiny is 
the Centers for Medicare and Medicaid 
Services’ Center for Medicare and 
Medicaid Innovation, with its mission 
of “Better health care, better health, and 
reduced costs through improvement”1 
coupled with an innovation investment 
portfolio of several billion dollars. Other 
contemporary examples include the 
Patient-Centered Outcomes Research 
Institute (PCORI), a private organization 
created as part of health reform to promote 
and support comparative effectiveness 
research and patient-centered outcomes 
research, with a planned public and private 
annual funding stream of several hundred 
million dollars, plus a wide range of 
initiatives driven by private health plans, 
care providers, and employers.2
Concurrently, defining and deriving 
the “value” of health care services has 
become substantially more complex as the 
number and diversity of key stakeholders 
has expanded. Attempts to reconcile 
views of value are a mix of observed or 
projected analytics to create clarity (and, 
in some cases, even presumed “certainty”) 
juxtaposed with major political debate and 
substantial disagreement about the key 
issues and goals that should be objectified. 
Although data are increasingly abundant 
and research and analytic tools have 
become more sophisticated, it also has 
become clear that the scope of value 
determination as it has been practiced in 
the past lacks generalizable application 
across the emerging concerns of the 
diverse set of stakeholders. More depth 
and dimension are needed to fully 
leverage the simple value equation of 
V(value)=Q(quality)/C(cost).
For a concept as complex as value, the 
evolution of its expanded meaning 
and application in measurement and 
prioritization of effort likely will require 
multiple incremental changes. The 
following 3 promising areas of important 
augmentation to the current derivation of 
“value” will be discussed and include: 
• The importance of reflecting and 
respecting multiple perspectives
•Appreciating what we don’t know 
about the care experience, and 
•Embracing that when there are 
multiple aims for improvement, you 
must address all concurrently.
The Importance of Perspective: “What  
Will it Take for the Patient and Payer to 
‘Get’ Value?” 
A few years ago at the Kaiser Permanente 
Care Management Institute, we 
systematically sought out and engaged 
groups of health system leaders, 
clinicians, patients, and payers to better 
understand how they perceived and 
evaluated “value” in health care. Initially, 
we wanted to know what would be 
required for the consumer/patient and 
employer/purchaser to understand 
“quality” and “value” as we perceived 
them from our perspective as managers 
of a large integrated delivery system. We 
saw value as best reflected by nested and 
explicitly defined measures of health 
care system structure, process, and 
health outcomes such as the Healthcare 
Effectiveness Data and Information Set 
Quality Indicators.3 However, the more 
complex value framework we eventually 
derived (Figure 1) reflected and, perhaps 
more importantly, respected the differences 
between key perspectives. 
Clinicians and health system leaders 
most frequently associated value with 
“traditional” metrics of clinical structure, 
process, and health outcomes whereas 
patients identified aspects of the 
care experience, such as convenience, 
respectful providers, and trusting 
relationships with their clinicians, 
as most critical for them in terms 
of engagement and as meaningful 
attributes of value. 
Not surprisingly, organizations and 
entities that provide payment for 
services, including public payers, private 
health plans, and major employers, 
identified financial metrics - especially 
affordability plus return on their health-
associated investments - as their leading 
indicators of value. Importantly, no payer 
suggested reducing costs by relaxing 
clinical quality standards. Rather, 
cost impact was generally identified 
as attainable through improved 
efficiency and reduction of waste. Each 
stakeholder’s perspective recognized 
and granted importance to the elements 
valued by other stakeholder perspectives, 
albeit with lower priority. However, 
each stakeholder assigned prime “value” 
to substantially different metrics. Each 
stakeholder perspective did “get quality,” 
but in its own manner. 
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Figure 1.  A Model of Health Care Value
Source: Bellows J, Sullivan MP. Could a quality index help us 
navigate the chasm? http://xnet.kp.org/ihp/publications/docs/
quality_background.pdf. Accessed July 11, 2012. 
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Other efforts also have addressed the 
impact of multiple perspectives on 
value perception and definition. A 
relatively encyclopedic consideration 
of the complexity of the challenge has 
recently been published by the Institute 
of Medicine.4 
Appreciating What We Don’t Know: The 
Complex Nature of the Care Experience  
Although patient-centeredness has 
been positioned securely as a basic 
element of quality, and hence value, 
since the sentinel Institute of Medicine 
quality reports of the last 2 decades, 
measurement frameworks to robustly 
reflect and capture a patient’s care 
experience have been problematic. Most 
recent progress has followed from the 
leadership of the Agency for Healthcare 
Research and Quality in developing and 
promoting standardized patient surveys 
such as the Consumer Assessment of 
Healthcare Providers and Systems family 
of instruments.5 Although the capability 
for doing such surveys is a significant 
achievement, additional complementary 
approaches to better bridge other forms 
of value-related measurement to the 
patient experience are needed. Today’s 
patients increasingly have multiple 
clinicians, often receive care in multiple 
locations, are responsible for major 
portions of their care while at home, 
and have little cohesion across settings 
other than themselves and their families. 
Consequently there is a need to move 
beyond an exclusive focus on what can 
be done to and for patients by providers 
and a health system. 
At a roundtable discussion of patient-
centeredness among several California 
and national health care leaders, the 
successful patient experience was equated 
with enabling patients to understand, 
participate in, and direct their own care. 
Examples included shared decision 
making, use of personal health records 
by patients and their clinicians, and 
programs for palliative and end-of-life 
care that require care decisions to be 
highly customized for, and dependent 
on, the patient and his or her family.6 
Building from this discussion, a value 
measurement framework that is 
informative across the patient experience 
should ideally include metrics that reflect:
•  Care delivered for the patient 
(eg, key prevention testing, case 
management, much of chronic 
condition management)
•  Care delivered with the patient,  
(eg, shared decision making,  
care coordination)
•  Care “delivered” by the patient and 
his or her family, ideally with health 
system support (eg, traditional self-
care, health behavior change, much 
of end-of-life support). 
In aggregate, a credible future value 
framework will need to both respect 
and reflect the varying loci of control for 
different aspects of the pursuit of health 
and delivery of health care.
The expanded national investment in 
the PCORI achieved as part of the 
ACA offers substantial leadership and 
funding to better understand how to 
engage and inform patients about their 
care and care experience. 
Addressing One Dimension of Value at 
a Time Is Not Enough- The Integrating 
Message of Concurrent Aims  
The value model in Figure 1 is a close 
analog of the Triple Aim proposed 
by the Institute for Healthcare 
Improvement (IHI) with its 3 
overarching goals to be addressed in 
pursuit of improved health system value.7 
The IHI specific aims are to:
•  Improve the health of the population; 
•  Enhance the patient experience of 
care (including quality, access, and 
reliability); and 
•  Reduce, or at least control, the per 
capita cost of care.7 
Very similar concepts – Better  
Care, Affordable Care, and Healthy 
People/Healthy Communities – now 
form the framework for the National 
Quality Strategy.8 
The Triple Aim and National Quality 
Strategy share a common core 
concept: Meaningful and sustainable 
value realization requires focused and 
coordinated improvement addressing 
all of the main dimensions of value 
at the same time. It is insufficient to 
focus exclusively on a single dimension 
- whether it be cost, quality, or the 
care experience - and expect the 
other dimensions to fall into line. For 
example, a common refrain in recent 
years – “if quality is addressed then 
cost improvement will follow” – has led 
to initiatives that fail to identify and 
pursue explicit timelines for addressing 
cost issues. Quality, as observed by the 
usual measures, has arguably improved 
while an equivalent impact on cost 
has remained on a future “to follow.” 
Similarly, the cost-focused efforts of the 
1990s failed to impact quality equally and 
adversely affected the care experience. 
The learning embodied in the Triple 
Aim is that true progress toward higher 
value health care requires progress in 
multiple dimensions simultaneously, 
with leadership and provider focus 
on managing and reconciling the 
inevitable conflicts and ambiguities 
inherent in having goals embedded 
in such a complex framework. As a 
hopeful sign, a growing number of 
organizations are now simultaneously 
achieving improvement across these 
multiple determinants of value. Common 
traits across the diverse mix of payers 
and providers achieving cross-cutting 
improvement include: 
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•Balance of system-based and 
individual changes.
•New ways to engage both providers 
and patients.
•Focus on population care.
•Use of health information technology.
Recently, others have provided 
guidance about how to effectively focus 
evaluations to gauge the full return on 
these investments.9 The most useful 
evaluations will be those that:
•Focus on change that matters. 
•Document innovations to support 
effective learning and dissemination.
•Balance flexibility and speed with 
rigor in developing evidence to 
support policy change.
Summary 
As efforts to reform health care financing 
and delivery intensify and come under 
increased scrutiny by varied stakeholders, 
gradual but significant progress is 
being made in evolving a durable and 
sustainable framework for measuring 
value. Key aspects of this emerging 
framework are respect for varying 
perspectives of value and substantial 
investments in better understanding and 
characterizing all dimensions of value 
- those most directly reflecting the care 
experience in particular. A hopeful sign is 
that a growing number of organizations 
are achieving concurrent improvements 
in multiple aspects of quality, cost, 
and the patient care experience, and 
the attributes and practices of these 
leading groups are being successfully 
characterized and spread. 
Paul Wallace, MD, is Senior Vice 
President and Director of the Center for 
Comparative Effectiveness Research, The 
Lewin Group. He can be reached at: paul.
wallace@Lewin.com. 
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A Black Swan Comes to Philadelphia 
By Jeffrey Brenner, MD
Have you ever wondered how the 
US health care landscape will evolve 
if, as some prefer, the system is not 
subjected to reforms and warnings 
about the consequences are ignored? I 
have, and I fear that by 2017 we might 
open our newspapers to read real 
stories like this one.
Philadelphia Inquirer 
3/20/2017
The President and CEO of Hamilton 
University Hospital emerged today after 
marathon discussions about the future of 
the organization with an announcement 
on the imminent closure of the 200-year-
old hospital. 
Accompanied by the mayor, he spoke to 
the large crowd of employees and local 
Philadelphia leaders. 
“We’ve done everything we can,” he said. 
“We’ll be shutting down by the end of the 
month. I expect an orderly and safe process 
to ensure that every patient receives the 
highest quality of care until the last day.”
The mayor said, “The bondholders have 
spoken and we are out of options. There are no 
more bailouts coming for our city’s hospitals.”
Hamilton will be the tenth academic health 
center in a major US city to close this year. 
When asked about the growing trend, a 
Brookings Institute health policy expert 
said, “After a series of bailouts by the federal 
government, the public appetite for rescuing 
hospitals has diminished.”
In 2015, twenty-five large academic health 
centers received federal loans through a 
still controversial Presidential decision - a 
rescue package totaling over $75 billion. 
None of the loans are expected to be repaid 
because the financial condition of the 
hospitals has worsened.
This newsletter was jointly developed and subject to editorial review by Jefferson School of Population Health and Lilly USA, LLC, and is supported through funding by Lilly USA, LLC. 
HE79414
12 Prescriptions for Excellence in Health Care
An American Association of Retired 
Persons spokesperson asked, “How can we 
justify spending more precious Medicare 
dollars on bailing out hospitals when 
Medicare patients can’t find a primary care 
provider to take care of them? Waiting lists 
in cities like Philadelphia have grown into 
the thousands for the average practice.”
A major bondholder for the hospital is 
expected to lose over $350 million in the 
closure of Hamilton University Hospital. 
When asked about this significant 
financial loss, its president said, “Events 
like this are not predictable. Along 
with the new management team at the 
hospital, we did the best we could to turn 
this around over the past year. But with 
changes in federal funding there was no 
way to make this work.”
The last few years have seen dramatic 
reductions in National Institutes of 
Health research spending, Medicare 
reimbursements, and pharmaceutical 
industry sponsorships, pushing many 
academic health centers in the US to the 
brink of bankruptcy. Most government 
budget experts cite the unexpected attack 
on American cities by foreign eco-
terrorists, angry over rising sea levels, for 
the current financial crisis in health care. 
A well-known economist noted, “The US 
economy was already in a weakened state 
after years of unemployment, economic 
stagnation, and political paralysis before 
the attacks. Also, we just weren’t ready for 
the tsunami of aging baby boomers. How 
could we have known the number of new 
expensive treatments that would come to 
the marketplace?”
Struggling foreign relations haven’t 
helped either, he added: “When the Chinese 
stopped buying our bonds, it really closed 
the door on our ability to keep bailing out 
hospitals in the US.”
When a world famous but terminally 
ill rock legend walked out of the ICU at 
a leading New York hospital in 2014, 
declaring that he would never die in a 
hospital, he began a trend among baby 
boomers that has spread quickly. The 
growing natural death movement has had 
an unexpected impact on the censuses in 
American hospital ICUs. 
One plan for the rescue of Hamilton 
Hospital had been a buyout from a 
large health insurance conglomerate. A 
spokesperson for the company said in a 
statement today, “We’ve bought over 20 
academic health centers this year, but 
the marketplace in Philadelphia is too 
overcrowded. We couldn’t see a pathway to 
profitability for this deal.”
Some experts say the nation has not 
seen this level of hospital closures since 
the 1950s and 1960s, when financial 
pressures forced states to shut psychiatric 
hospitals in droves. 
“Look what a mess we made when waves 
of mentally ill patients were released from 
psychiatric hospitals and overran urban 
communities without adequate outpatient 
services,” said a prominent US history 
professor. “We are similarly unprepared for 
the consequences of deinstitutionalizing 
medical care in our country today.”
The closure of Hamilton Hospital is 
expected to have painful consequences 
for a city already reeling from record 
unemployment, falling housing prices, 
and significant reductions in student 
enrollment at the city’s flagship 
educational institution. 
“The Eds and Meds model is over,” said 
a spokesperson for Philadelphia’s business 
community. “Philadelphia needs to find a 
new economic driver.”
At today’s press conference, nurses said they 
offered concessions to keep Hamilton open. 
“We made significant offers for voluntary cuts 
to our wages and benefits. We did our part 
but it wasn’t enough to save the hospital.”
In the last 4 years many nurses across the 
US have shifted from working in hospitals 
to home-based care.
Standing in front of Hamilton Hospital 
as the announcement was made were 
hundreds of residents and interns dressed 
in white coats and scrubs. They looked 
shocked as they realized their training 
programs would be disbanded.
A fourth-year surgery resident said, “All 
of us have over $400,000 in loans. If we 
can’t finish our training how will we ever 
pay off this debt? With the increasing 
number of hospital closures across the 
country, there are no more residency slots 
available. Now I might be headed abroad 
to finish my training.”
A growing number of hospitals in foreign 
countries have begun to recruit American 
medical school graduates and trainees to 
complete their training. With the closure of 
places like Hamilton Hospital this trend is 
expected to accelerate.
The “news item” might go on, but the 
message should already be clear. Without 
willingness to recognize these enormous 
problems and their consequences – and 
without a collective commitment to 
change – it is certainly possible that we 
will be faced with this type of scenario in 
the not-too-distant future. 
Jeffrey Brenner, MD is Founder and 
Executive Director of the Camden 
Coalition of Healthcare Providers. He can 
be reached at: Jeffrey.brenner@verizon.net.
